The Impact of Dendritic Cell Therapy

For anyone facing a cancer diagnosis, the need for reliable, transparent information is paramount.

Dendritic Cell Therapy represents a significant breakthrough in cancer cure, and here we will share what makes it so remarkable. From peer-reviewed studies to clinical successes and global recognition, we aim to provide a clear and honest view of the therapy’s progress and potential.

Recognised Achievements

Highlighting global recognition underscores the credibility of this approach:

Nobel Prize in Physiology or Medicine (2011):

Awarded to Dr. Ralph Steinman for discovering the immune function of dendritic cells, foundational to this therapy.

Sjöberg Prize (2024):

Honouring advancements in dendritic cell-based cancer therapies.

Albert Lasker Award:

Celebrating groundbreaking research on dendritic cell functions and their application in oncology.

Key Clinical Findings

Knowing how the therapy performs in real-world settings is critical. Here are some notable results:

Glioblastoma

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial

Pancreatic Cancer

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer

Multiple Myeloma

“A Phase I Clinical Study of Autologous Dendritic Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma”

Access to Peer-Reviewed Research

Many people want to dive deeper into the science behind new therapies.
These studies provide a deeper understanding:

"First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma"

"Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old"

"Dendritic Cell-Based Immunotherapy in Patients with Resected Pancreatic Cancer: A Promising Strategy for Preventing Recurrence"

What This Means for You

Dendritic Cell Therapy is supported by extensive research and clinical trials, but it’s still evolving. This means it may not be suitable for everyone, and it’s essential to explore all options with your oncologist. We invite you to learn more, explore the studies, and contact us to discuss whether this innovative approach could benefit you or your loved one.